Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds VolitionRx Reports FY22 Cash $10.9M

VolitionRx Reports FY22 Cash $10.9M

Cash and cash equivalents as of December 31, 2022 totaled approximately $10.9 million.

byBenzinga Newsdesk

March 15, 2023

1 minute read

Cash and cash equivalents as of December 31, 2022 totaled approximately $10.9 million.

Why Cigarette Maker Philip Morris International Stock Is Plunging Today

By Shivani Kumaresan

April 20, 10:42 AM

Philip Morris International Inc (NYSE:PM) reported a first-quarter FY23 sales increase of 3.5% year-on-year to $8.02 billion, missing the analyst consensus…

Berenberg Upgrades Tesla to Buy, Lowers Price Target to $200

By Benzinga Newsdesk

January 30, 6:27 AM

Berenberg analyst Adrian Yanoshik upgrades Tesla (NASDAQ:TSLA) from Hold to Buy and lowers the price target from $255 to $200.

TSLA

California Faces Rising Gasoline Prices, Division of Petroleum Market Oversight Raises Concerns

By Vandana Singh

September 26, 12:35 PM

In response to rising gasoline price concerns, Tai Milder, the director of California's Division of Petroleum Market Oversight (DPMO), has

BNO

$1000 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth This Much Today

By Benzinga Insights

July 28, 3:30 PM

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 13.39% on an annualized basis…

IDXX

VolitionRx Reports FY22 Cash $10.9M

Related Posts

Why Cigarette Maker Philip Morris International Stock Is Plunging Today

Berenberg Upgrades Tesla to Buy, Lowers Price Target to $200

California Faces Rising Gasoline Prices, Division of Petroleum Market Oversight Raises Concerns

$1000 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth This Much Today